ArticlebioRxiv : the preprint server for biology2025
Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model.
Edward Jacobs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.